Risk of hospitalization during influenza season among a cohort of patients with congestive heart failure

Epidemiology and Infection

Volumn 135, Issue 4, 2007, Pages 574-582

  Sandoval, C ^a   Walter, S D ^a   Krueger, P ^a   Smieja, M ^a   Smith, A ^a   Yusuf, S ^a   Loeb, M B ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENALAPRIL; PLACEBO;

ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DATA BASE; ENVIRONMENTAL TEMPERATURE; HEALTH SURVEY; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INFLUENZA; MORTALITY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SEASONAL VARIATION; UNITED STATES;

COHORT STUDIES; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 34247506793     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S095026880600714X     Document Type: Article

References (32)

1. Simonsen L, et al. The impact of influenza epidemics on mortality: Introducing a severity index. American Journal of Public Health 1997; 87: 1944-1950.
2. Laboratory Centre for Disease Control. Canadian consensus conference on influenza. Canadian Communicable Disease Report 1993; 19: 136-146.
3. Centers for Disease Control and Prevention. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports 2005; 54: 1-40.
4. National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2005-2006 season. Canadian Communicable Disease Report 2006; 31 (ACS-6).
5. Glezen WP, et al. Impact of respiratory virus infections on persons with chronic underlying conditions. Journal of the American Medical Association 2002; 283: 499-505.
6. McBean AM, Babish JD, Warren JL. The impact and cost of influenza in the elderly. Archives of Internal Medicine 1993; 153: 2105-2111.
7. Barker WH. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-1978. American Journal of Public Health 1986; 76: 761-765.
8. Upshur REG, Knight K, Vivek G. Time-series analysis of the relation between influenza virus and hospital admissions of the elderly in Ontario, Canada, for pneumonia, chronic lung disease, and congestive heart failure. American Journal of Epidemiology 1999; 149: 85-92.
9. American Heart Association. Congestive heart failure (http://www.americanheart.org/presenter.jhtml?identifier = 1486). Accessed 9 August 2006.
10. Wilson E. Congestive heart failure: A national priority. Canadian Journal of Cardiology 2001; 17: 1243-1244.
11. Simonsen L, et al. The impact of influenza epidemics on mortality: Introducing a severity index. American Journal of Public Health 1997; 87: 1944-1950.
12. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New England Journal of Medicine 1991; 325: 293-302.
13. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. New England Journal of Medicine 1992; 327: 685-691.
14. The SOLVD Investigators. Studies of left ventricular dysfunction - rationale, design, and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. American Journal of Cardiology 1990; 66: 315-322.
15. Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases 1987; 40: 373-383.
16. Nichol KL, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. New England Journal of Medicine 2003; 348: 1322-1332.
17. Nordin J, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: Data from 3 health plans. Journal of Infectious Diseases 2001; 184: 665-671.
18. Allison PD. Survival Analysis Using the SAS System: A Practical Guide. Cary, NC: SAS Institute Inc., 1995.
19. Criteria Committee of the American Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, 9th edn. Boston, MA: Little, Brown & Co., 1994, pp. 253-256.
20. Thompson WW, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. Journal of the American Medical Association 2003; 289: 179-186.
21. Wilkinson P, et al. Vulnerability to winter mortality in elderly people in Britain: Population based study. British Medical Journal 2004; 329: 647.
22. Stewart S, et al. Heart failure in a cold climate. Journal of the American College of Cardiology 2002; 39: 760-766.
23. van Rossum CTM, et al. Seasonal variation in cause-specific mortality: Are there high-risk groups? 25-year follow-up of civil servants from the first Whitehall Study. International Journal of Epidemiology 2001; 30: 1109-1116.
24. Boulay F, et al. Seasonal variation in chronic heart failure hospitalizations and mortality in France. Circulation 1999; 100 280-286.
25. Curriero FC, et al. Temperature and mortality in 11 cities of the Eastern United States. American Journal of Epidemiology 2002; 155: 80-87.
26. Barnett AG, et al. Cold periods and coronary events: An analysis of populations worldwide. Journal of Epidemiology and Community Health 2005; 59: 551-557.
27. Reichert TA, et al. Influenza and the winter increase in mortality in the United States, 1959-1999. American Journal of Epidemiology 2004; 160: 492-502.
28. Noble GR. Epidemiological and clinical aspects of influenza. In: Beare AS, ed. Basic and Applied Influenza Research. Boca Raton, FL: CRC Press; 1982, pp. 11-50.
29. Nguyen-Van Tam JS. Epidemiology of influenza. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of Influenza. Oxford, England: Blackwell Science, 1998, pp. 181-206.
30. Centers for Disease Control and Prevention. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommendations and Reports 2000; 51 (No. RR-3).
31. Centers for Disease Control and Prevention. Surveillance Summaries, October 25, 2002. MMWR Surveillance Summaries 2002; 51 (No. SS-7).
32. Neuzil KM, et al. Winter respiratory viruses and health care use: A population-based study in the northwest United States. Clinical Infectious Diseases 2003; 37: 201-207.